United States · Funded startup
9 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Cellerant Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 27 Oct 2026
$96Mraised across 9 rounds since 2005, from 9 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
No investor was named in the report.
From a historical funding recordSEC filing: $2.2M sold, first sale Jan 2014
Allen & CompanyReported by sec.govSEC filing: $2.1M sold, first sale Sept 2012
No investor was named in the report.
Reported by sec.govSEC filing: $800K sold, first sale Jul 2011
No investor was named in the report.
From a historical funding recordSEC filing: $1.0M sold, first sale Dec 2010
No investor was named in the report.
From a historical funding recordSEC filing: $2.3M sold, first sale Jan 2010
MPM CapitalAllen & CompanyReported by cellerant.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
MPM CapitalAllen & CompanyNovel BioventuresBARDAGeorge Rathmann
Camelot Venture GroupCamelot CollectablesCX Venture GroupMissing a round, or an investor who was in one? Tell us.
Cellerant Therapeutics's investors include MPM Capital, Allen & Company, Novel Bioventures, BARDA and George Rathmann, and 3 more on record.
Cellerant Therapeutics has raised $96M across 9 rounds since 2005.
Cellerant Therapeutics's most recent round was a Grant of $48M in Sept 2014.
Its most recent round, $48M in Sept 2014, is also its largest on record.
Cellerant Therapeutics's first round on record, in May 2005, was backed by MPM Capital, Allen & Company and Novel Bioventures and 2 others.
Cellerant Therapeutics's latest named round is a Grant, in Sept 2014.
Cellerant Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
